Dr. Cobert is a gastroenterologist with over 25 years in the pharmaceutical industry with senior positions in drug safety and clinical research. He is now consulting in drug safety, quality and clinical research.

He received formal training in infectious diseases and molecular mechanisms of pathogenesis and has more than 15 years of experience directing global product development and registration programs. He also has extensive experience in pharmacovigilance and health informatics as well as the evaluation and exchange of safety data. He has served with other experts and senior scientists on many consensus panels, including ICH, CIOMS, ISO, and HL7.